Scientists at UC San Francisco and at Gladstone Institutes have identified a combination of two anticancer drugs that the researchers suggest may reverse the changes that occur in the brain during ...
The Brighterside of News on MSN
Experimental drug can sharply reduce amyloid beta's impact on Alzheimer’s
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Morning Overview on MSN
Scientists "cured" Alzheimer's in mice, are humans next?
Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...
Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...
Summary: Researchers have created a new experimental model that reveals how changing a key Alzheimer’s risk gene can shift ...
A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the brain's protective shield - known as the blood-brain barrier (BBB) - ...
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease. In a new study, Northwestern scientists identified a ...
In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4 protein - the most important genetic risk factor for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback